JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis
Jianling Tao(Stanford University), Richard Lafayette(Stanford Medicine)
Cited by 96
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome
|The American Journal of Human Genetics|2018|184